Global Pollen Allergies Market, By Product (Instruments, Consumables, and Services), Allergen Type (Food, Inhaled, Drug, and Others), Diagnostics Test (In Vivo Test and In Vitro Test), Therapeutics Drug Class (Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitor, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy), End User (Diagnostic Laboratories, Hospitals, and Academic Research Institutes) – Industry Trends and Forecast to 2030.
Pollen Allergies Market Analysis and Size
Major factors that are expected to boost the growth of the pollen allergies market in the forecast period are the rapid urbanization in the advancing countries. Furthermore, the increase in greenhouse gas can result in pollen-induced reparative disease, which is further estimated to cushion the growth of the pollen allergies market. In addition, the increase in environmental pollution will further provide opportunities for the growth of the pollen allergies market in the coming years.
Data Bridge Market Research analyses that the global pollen allergies market which was USD 5,850.84 million in 2022, would rocket up to USD 8,828.63 million by 2030 and is expected to undergo a CAGR of 4.2% during the forecast period. “Instruments” dominates the product segment of the market owing to the high demand for this type of product.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pollen Allergies Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015-2020)
Revenue in USD Million, Volumes in Units, Pricing in USD
By Product (Instruments, Consumables, and Services), Allergen Type (Food, Inhaled, Drug, and Others), Diagnostics Test (In Vivo Test and In Vitro Test), Therapeutics Drug Class (Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy), End User (Diagnostic Laboratories, Hospitals, and Academic Research Institutes)
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America
Market Players Covered
ALK-Abello (Denmark), Circassia (U.K.), DBV Technologies (France), Genentech (U.S.), GlaxoSmithKline (U.K.), HAL Allergy Group (Netherlands), Johnson & Johnson (U.S.), Meda AB (Sweden), Merck & Co. (U.S.)., Mylan (U.S.), Novartis AG (Switzerland), Omega Pharma (Belgium), Pfizer (U.S.), Regeneron Pharmaceuticals (U.S.), Sanofi (France), Stallergenes Greer (U.K.), and Teva Pharmaceuticals (Israel)
Pollen allergies, also known as hay fever or allergic rhinitis, are a type of allergic reaction that occurs when the body's immune system overreacts to pollen from trees, grasses, weeds, and other plants. Pollen is a fine powder plants produce as part of their reproductive process. When someone with a pollen allergy inhales pollen, their immune system mistakenly identifies it as a harmful substance and produces antibodies to fight it. This triggers the release of chemicals, such as histamine, which cause various symptoms, including sneezing, runny or stuffy nose, itchy and watery eyes, itchy throat, and coughing.
Pollen Allergies Market Dynamics
- Increasing prevalence of allergies
Pollen allergies are becoming more common, with an estimated 10-30% of adults and up to 40% of children affected worldwide. This increasing prevalence of allergies is driving demand for pollen allergy treatments.
- Growing awareness of allergies
As more people are diagnosed with allergies, there is a growing awareness of the need for effective treatments. This is leading to increased demand for pollen allergy treatments and driving growth in the market.
- Growing investment in healthcare facilities
Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering market growth. The rising number of partnerships and strategic collaborations between the public and private players about funding and application of new and improved technology further creates lucrative market opportunities.
- Advancements in treatment options
There have been significant advancements in pollen allergy treatments in recent years, including new types of antihistamines, nasal sprays, and immunotherapy. These innovations are driving growth in the market by providing patients with more effective and convenient treatment options.
Increasing investment in research and development
Many pharmaceutical companies are investing heavily in R&D of new pollen allergy treatments. This is driving innovation in the market and leading to the development of new and more effective treatments.
- Lack of effective treatments
While many treatments are available for pollen allergies, some patients may not respond well to existing treatments or experience side effects. This can make it difficult to manage symptoms effectively and can lead to patient dissatisfaction.
High cost of treatment
Some pollen allergy treatments, such as immunotherapy, can be expensive and not covered by insurance. This can limit access to treatment for some patients and create financial barriers to care.
This pollen allergies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Pollen allergies Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
- In 2020, ALK-Abello launched a new sublingual allergy immunotherapy tablet for grass pollen allergies. The tablet is designed to be taken at home and provides patients with a more convenient treatment option
- In 2020, DBV Technologies announced that it had received FDA approval for its patch-based immunotherapy product for peanut allergies. The company is also developing treatments for other food allergies and is exploring the use of its technology for other types of allergies.
Global Pollen Allergies Market Scope
The pollen allergies market is segmented on the basis of product, allergen type, diagnostic test, therapeutics drug class, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- In Vivo Test
- In Vitro Test
Therapeutic Drug Class
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anticholinergics
- Auto injectable Epinephrine
- Diagnostic Laboratories
- Academic Research Institutes
Pollen allergies Market Regional Analysis/Insights
The pollen allergies market is analysed and market size insights and trends are provided by country, product, allergen type, diagnostic test, therapeutic drug class, and end users as referenced above.
The countries covered in the pollen allergies market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
North America dominates the pollen allergies Market because of the strong base of healthcare facilities, the strong presence of major players in the market, and the rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The pollen allergies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Pollen allergies Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Pollen allergies Market. The data is available for historic period 2010-2020.
Competitive Landscape and Pollen Allergies Market Share Analysis
The pollen allergies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pollen allergies market.
Some of the major players operating in the market are:
- ALK-Abello (Denmark)
- Circassia (U.K.)
- DBV Technologies (France)
- Genentech (U.S.)
- GlaxoSmithKline (U.K.)
- HAL Allergy Group (Netherlands)
- Johnson & Johnson (U.S.)
- Meda AB (Sweden)
- Merck & Co. (U.S.)
- Mylan (U.S.)
- Novartis AG (Switzerland)
- Omega Pharma (Belgium)
- Pfizer (U.S.)
- Regeneron Pharmaceuticals (U.S.)
- Sanofi (France)
- Stallergenes Greer (U.K.)
- Teva Pharmaceuticals (Israel)